ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS)

Historical Holders from Q3 2024 to Q2 2025

Symbol
RSLS on Nasdaq
CUSIP
76090R309
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
3.33M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-9
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIGGER CAPITAL FUND L P 9.68% $147K 320K Bigger Michael Feb 18, 2025
CVI Investments, Inc. 5.7% -42% $92K -$66.5K 200K -42% CVI Investments, Inc. Mar 31, 2025
FirstFire Global Opportunities Fund LLC 6.1% $92K 200K FirstFire Global Opportunities Fund LLC Feb 18, 2025
Ayrton Capital LLC 5.71% $92K 200K Ayrton Capital LLC Mar 31, 2025
Leonite Fund I, LP 6.1% $92K 200K Leonite Fund I, LP Feb 18, 2025
Dominion Capital LLC 0.76% -91.4% $11.6K -$24.4K 25.3K -67.7% Dominion Capital LLC Feb 18, 2025

Institutional Holders of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$37.4K 0
2025 Q1 104K $37.4K +$30.5K $0.36 9
2024 Q4 19.1K $85.2K +$79.6K $4.46 8
2024 Q3 1.26K $7.14K +$3.82K $5.88 8